Are ASCs Safe for Total Joints? What the Outcomes Data Shows
Do ASC total joints have worse outcomes? Registry data on 90-day readmissions and ER visits — plus the patient-selection caveat that explains the numbers.
"Are ASC total joints safe?" is the question every administrator, surgeon, and patient asks before a hip or knee replacement leaves the hospital. The honest, data-grounded answer is encouraging — for appropriately selected patients — but the way the outcomes data is usually quoted hides the most important part of the story. This post walks through what large registry data actually shows on 90-day readmissions and ER visits, and the selection caveat that explains the numbers.
It pairs with the economics of ASC total joints and the broader outpatient total joint arthroplasty pillar — because safety and financial viability are the two questions a program has to answer together.
The safety question administrators and patients ask
The worry is intuitive: a total joint is major surgery, and sending the patient home the same day from a freestanding center — without an inpatient floor or a hospital's rapid-response infrastructure down the hall — feels riskier than an admission. So the question is whether outpatient, ASC-based total joints show worse 30- and 90-day outcomes, particularly readmissions and emergency-department visits.
The data says no. But why it says no is the part you have to get right.
What large registry data shows
A Michigan Arthroplasty Registry Collaborative Quality Initiative (MARCQI) analysis of roughly 41,700 total joints compared 30- and 90-day outcomes across ASC, HOPD, and hospital settings. ASCs had the lowest readmission and ER-visit rates of the three at both time points. For total hip arthroplasty, for instance, 90-day readmissions were about 1.7 percent in ASCs versus 5.5 percent in hospitals; the pattern held for total knee and for ER visits.
Supporting work agrees in selected populations: a practice-owned ASC migration series reported significant improvements in hip and knee patient-reported outcomes at six months with low complication rates, and an academic-center short-stay pathway analysis found comparable-to-better readmission rates versus inpatient discharge.
90-day readmissions after total hip arthroplasty in ASCs versus hospitals in a ~41,700-case Michigan registry analysis — with a major selection caveat.
Puri et al., Arthroplasty Today, 2025
The selection-bias caveat behind the numbers
Read alone, those figures say "ASCs are safer." The same registry study is explicit about why that reading is wrong.
ASC patients were, on average, younger, healthier, and more strictly selected. The hospital cohort carried higher proportions of older patients, higher ASA class, obesity, diabetes, and other risk factors. The ASC did not make those patients low-risk — they were chosen because they were low-risk. The outcomes reflect patient selection at least as much as the site of care.
Selection, not setting
The defensible conclusion is narrow and important: in appropriately selected patients, the ASC is a safe place to do a total joint, with low readmission and ER-visit rates. It is not evidence that any given patient does better in an ASC. Quoting the headline rates without the selection caveat is the most common way this data gets misused.
What this means for your patient-selection protocol
Because outcomes track selection so tightly, the selection protocol is not paperwork — it is the safety system. Specific thresholds belong to each program's surgeons, anesthesiologists, and medical directors, but selection generally weighs age and physiologic reserve (rather than a hard age cutoff), BMI, the degree of control of cardiopulmonary and metabolic comorbidities, ASA physical status class, and the patient's home support and discharge environment.
The point is less the exact list than its discipline: the criteria must be written down, applied consistently, and revisited as your own outcomes data accrues. A selection protocol that drifts case to case is the fastest way to turn a safe program into an unsafe one — and to turn good registry numbers into your own bad ones.
How ORbit supports selection and tracking
Safe outpatient joints depend on a loop: select carefully, then watch your own outcomes to confirm the selection is working and tighten it where it isn't. ORbit supports the operational side of that loop — facility-scoped, median-based tracking of your case mix and outcomes over time, broken out by surgeon and service line — so a program can see whether its results match the registry's reassuring averages on its patients, not someone else's. Combined with the efficiency analytics that keep the program financially viable, it is part of running outpatient total joints as a disciplined, data-driven service line. To see it on your own data, book a walkthrough.
Frequently asked questions
Are total joints safe to do in an ASC?
For appropriately selected patients, the registry data is reassuring. A Michigan Arthroplasty Registry analysis of roughly 41,700 total joints found ASCs had the lowest 30- and 90-day readmission and emergency-department visit rates of the three settings studied. The crucial caveat is that ASC patients were younger, healthier, and more strictly selected — so the result reflects selection as much as setting.
Do ASC total joints have lower readmission rates than hospitals?
In the Michigan registry data, yes — for example, 90-day readmissions after total hip were about 1.7 percent in ASCs versus 5.5 percent in hospitals. But ASC patients were a lower-risk group by design, so the comparison is not apples-to-apples and should not be read as proof the setting itself is safer for any given patient.
What makes an ASC total joint program safe?
A disciplined, written patient-selection protocol applied consistently, plus tracking of outcomes over time. Because outcomes track selection so closely, the selection criteria — age and physiologic reserve, BMI, controlled comorbidities, ASA class, and home support — are the most important operational decision in the program.